Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Utility of CYP2D6 genotyping to improve tramadol efficacy and safety in acute postoperative pain
2022-500377-13-01Phase 4Authorised
- Sponsor
- Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tramadol in acute postoperative pain (2 arms), sponsored by Fundación de Investigación Biomédica del Hospital Universitario de La Princesa. Primary endpoint: Study completion without early termination. Planned start May 2022; status: authorised.
02
Drugs
tramadol
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on 2022-500377-13-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500377-13-01.